Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu Zeng

Showing results (191-200 of 192) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 192 results.
Bioorganic & Medicinal Chemistry Letters|April 18, 2022
Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)Jianyu Lu, Chi-Chung Chan, Deheng Sun, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 15, 2024
Clinicopathologic, Proteomic and Outcome Characteristics of Renal Apolipoprotein C-II Amyloidosis: A Case SeriesSamih H Nasr, Surendra Dasari, Anthony M Valeri, et al.
Pageof 20

Showing results (191-200 of 192) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 192 results.
Bioorganic & Medicinal Chemistry Letters|April 18, 2022
Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)Jianyu Lu, Chi-Chung Chan, Deheng Sun, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 15, 2024
Clinicopathologic, Proteomic and Outcome Characteristics of Renal Apolipoprotein C-II Amyloidosis: A Case SeriesSamih H Nasr, Surendra Dasari, Anthony M Valeri, et al.
Pageof 20